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Objective: The Revised Cardiac Risk Index (RCRI) is a widely used
model for predicting cardiac events after noncardiac surgery. We tested the
accuracy of the RCRI in vascular surgery patients compared with a specific
model developed from these patients.
Methods: We studied the 1014 patients undergoing open abdominal
aortic aneurysm repair (OAAA) and 2731 undergoing lower extremity
bypass (LEB) within the Vascular Study Group of Northern New England
between 2003 and 2008. The main outcome measure was a composite of
in-hospital myocardial infarction, arrhythmia, or congestive heart failure
(CHF). Univariate predictors were identified by 2 analysis. Multivariate
logistic regression was used to develop a risk prediction model for cardiac
complications. Calibration andmodel discrimination were assessed using the
Pearson correlation coefficient and receiver operating characteristic (ROC)
curves. We compared RCRI and our model’s ability to predict cardiac
complications within our cohort.
Results: Multivariate analysis showed cardiac events after LEB were
associatedwithmale gender, age80 years, diabetes, CHF, chronic obstructive
pulmonary disease (COPD), abnormal stress test, statin therapy, and critical
limb ischemia (odds ratios [OR] 0.8, 2.4, 1.6, 1.8,1.7, 2.0, 1.4, and 1.9) while
events after OAAA were associated with age 70 years, chronic -blocker
therapy, CHF, COPD, coronary artery bypass grafting/percutaneous coronary
angioplasty, abnormal stress test, creatinine 1.8 mg/dL, previous vascular
surgery, and living status (OR, 5.0, 3.0, 2.0, 1.7, 0.6, 1.9, 2.0, 1.6, and 21.0).
TheLEBandOAAAmodelswerewell calibrated (r0.98,P .001; r0.94,
P  .002) demonstrating moderate discriminative ability (ROC  0.70 and
0.71). Although our models predicted cardiac risk well, RCRI underestimated
risk, especially for higher-risk patients.
Conclusions: The RCRI substantially underestimates cardiac events in
high-risk patients undergoing OAAA and LEB. Our model more accurately
predicts cardiac events in vascular surgery patients.
Table. Predicted vs actual cardiac event rates after OAAA
and LEB based on RCRI and VSGNNE risk factors
RCRI predicted vs actual VSGNNE predicted vs actual
Risk
factors
No.
Predicted,
%
LEB
actual,
%
OAAA
actual,
%
Risk
factors,
No.
LEB
predicted,
%
LEB
actual,
%
OAAA
predicted,
%
OAAA
actual,
%
0 0.4 1.5 4.8 1 1.5 0 4.1 3.1
1 1.0 4.1 8.1 2 2.6 3.4 8.5 9.9
2 2.4 8.6 15.3 3 4.0 6.6 16.4 19.0
3 5.4 8.7 33.3 4 6.0 8.6 21.6 17.2
5 9.3 9.0 28.8 32.8
6 14.0 14.1 38.5 41.6
7 21.5 23.4 NA NA
LEB, Lower-extremity bypass;NA, not applicable; OAAA, open abdominal
aortic aneurysm repair; RCRI, Revised Cardiac Risk Index; VSGNNE,
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Introduction: Evidence suggests inhibition of cholesterol synthesis
with statins has a beneficial effect on atherosclerotic plaque in a variety of
vascular diseases. This study hypothesized that preoperative statin therapy
would have a protective effect on patients undergoing elective abdominal
aortic aneurysm (AAA) repair owing to the pleiotropic effect of these agents.
Methods: Analysis was performed of all patients who underwent an
elective endovascular aortic aneurysm repair (EVAR) or open AAA repair
(open) between 2004 and 2007. Clinical end points included postoperative
days, hospital length of stay, postoperative complications (myocardial infarc-
tion, stroke, renal failure, bleeding, pneumonia, urinary tract infection,
wound infection), and 30-day mortality. The financial end point was total
cost associated with the procedure.
Results: We identified 401 cases: 173 EVAR (43%) and 228 open
(57%). Despite a higher Society for Vascular Surgery risk score, the EVAR
statin cohort had significantly reduced postoperative days and hospital
length of stay. Postoperative complications and mortality were significantly
decreased in the open statin cohort. Financially, statin therapy translated
into improved total cost per patient in both treatment groups (Table, P 
.05). These findings are irrespective of preoperative -blockade, renin-
angiotensin system inhibitors, antiplatelet therapy, lipid profile, and smok-
ing status.
Conclusion: Statin therapy has a beneficial effect on patients undergo-
ing elective AAA repair with respect to clinical outcome measures and
subsequent resource utilization. These data demonstrate that preoperative
statin therapy should be an integral part of the preoperative optimization of
patients undergoing AAA repair, regardless of treatment modality, risk
score, or lipid profile.
Despite Higher Utilization of Carotid Angioplasty and Stenting (CAS)
in 2006, Postprocedure Stroke, Mortality Rates, Hospital Charges,
and Discharges to Nursing Skilled Facilities Remain Higher for CAS
than for Carotid Endarterectomy Compared with 2005
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Objective: This study compared, at the national level, trends in utili-
zation, mortality, and stroke of carotid angioplasty and stenting (CAS) and
carotid endarterectomy (CEA) during 2005-2006.
Methods: The Nationwide Inpatient Sample was queried for 2005-
2006 for patient discharges with International Classification of Diseases, 9th
revision, Clinical Modification codes for CAS and CEA. The primary out-
comes were in-hospital mortality, stroke, hospital charges, and discharge
disposition. Subgroup analyses were performed to evaluate these outcomes
by neurologic presentation using Wald 2 and multivariable logistic regres-
sion.
Results: Of 270,805 discharges for carotid revascularization, CAS use
was 66% higher in 2006 than in 2005 (9.3% vs 14%, P  .0004). In both
years, crude mortality, stroke, and median charges remained higher for CAS
than for CEA; discharge to home was more common after CEA. By logistic
Table. Outcomes of treatment, with and without statins,
for endovascular and open repair of abdominal aortic
aneurysm
Outcome EVAR Open
Statin No statin Statin No statin
(n  91) (n  82) (n  92) (n  136)
SVS risk score 7.9  0.4a 7.2  0.5 7.3  0.4a 5.9  0.3
Complications, % 2.4 2.4 1.7a 8.7
Death, % 0.0 1.8 0.0 a 3.5
Length of stay 2.3  0.3a 2.8  0.4 8.2  0.6 9.1  0.5
Post-op days 1.9  0.2a 2.3  0.3 7.2  0.6 7.8  0.5
Total cost, $ 33,237 
1041.6a
36,442 
1274.4
18,647 
1230.9a
22,440 
1571.7
Continuous data are mean  standard deviation.
EVAR, Endovascular aneurysm repair; SVS, Society for Vascular Surgery.
aP  .05.regression of the total cohort in 2005 and 2006, CAS was independently
predictive of mortality (odds ratio [OR] 1.7; 95% confidence interval [CI],
